RIGLRigel Pharmaceuticals, Inc.
$48.17+57% 1Y
$48.17
$25.4452 weeks$50.96
Is the price fair?
What RIGL's price assumes
Rigel Pharmaceuticals, Inc. trades at 2.85× earnings against 19.8× for the median Biotechnology name, cheaper than its own group.
2.85
Trailing P/E · Biotechnology median 19.8 · cheaper than the typical name in its group
- Price / sales
- 2.77
Price / sales · as of 2026-Q2
- Price / book
- 1.80
Price / book · as of 2026-Q2
- EV / sales
- 2.57
EV / sales
Details›
- Price / bookas of 2026-Q2
- 1.80
- EV / EBITas of 2026-Q2
- 8.16
- EV / salesas of 2026-Q2
- 2.57
- Healthcare median P/E503 names
- 27.9
- Biotechnology median P/E242 names
- 19.8
- Market capitalisation18.7 million shares, counted Jul 30, 2026
- $900M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.